What is BioSig Technologies, Inc.'s G&A?

BioSig Technologies, Inc. (STEX) reported G&A of $34.25M in Q1 2026.

How has BioSig Technologies, Inc.'s G&A changed year-over-year?

BioSig Technologies, Inc.'s G&A increased by 1058.4% year-over-year, from $2.96M to $34.25M.

What is the long-term trend for BioSig Technologies, Inc.'s G&A?

Over 4 years (2021 to 2025), BioSig Technologies, Inc.'s G&A has grown at a 24.8% compound annual growth rate (CAGR), from $27.85M to $67.53M.

Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

BioSig Technologies, Inc. STEX G&A

Discontinued — last reported Q1 '26

G&A at other companies

Bit DigitalBTBT

$27.63M+235%

DigitalBridge GroupDBRG

$19.74M+23.8%

Segments

By segment

See full

Corporate$8.88M+906%

Other financials

Income statement

See full

Revenue$13.0K+8.3%

Gross profit$12.0K-88.9%

Operating income-$35.7M-1,098%

Net income-$46.7M-1,560%

EPS (diluted)-$0.27-92.9%

Balance sheet

See full

Cash & equivalents$6.9M+84.0%

Total debt$15.0K-94.7%

Total equity$159.0M+6,003%

Total assets$173.3M+3,823%

Cash flow

See full

Operating cash flow-$10.2M-813%

CapEx$4.0K-93.1%

Free cash flow-$2.9M+29.4%

Valuation

See full

Market cap$88.66M-56.4%

P/S2,216.6×-5,967×

Profitability

See full

Gross margin80.1%+25.2pp

Operating margin-32,155%-14,261pp

Net margin-25,825%-11,789pp

FCF margin-97,216.7%-106,293pp

Returns & leverage

See full

Return on equity-627.1%—

Debt / equity0×—

Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioSig Technologies, Inc.'s G&A?: BioSig Technologies, Inc. (STEX) reported G&A of $34.25M in Q1 2026.
How has BioSig Technologies, Inc.'s G&A changed year-over-year?: BioSig Technologies, Inc.'s G&A increased by 1058.4% year-over-year, from $2.96M to $34.25M.
What is the long-term trend for BioSig Technologies, Inc.'s G&A?: Over 4 years (2021 to 2025), BioSig Technologies, Inc.'s G&A has grown at a 24.8% compound annual growth rate (CAGR), from $27.85M to $67.53M.
What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.